Opticrom and Anaphylaxis - a phase IV clinical study of FDA data

Summary:

Anaphylaxis is reported as a side effect among people who take Opticrom (cromolyn sodium), especially for people who are female, 30-39 old, also take Xolair, and have Asthma.

The phase IV clinical study analyzes which people have Anaphylaxis when taking Opticrom. It is created by eHealthMe based on reports of 93 people who have side effects when taking Opticrom from the FDA, and is updated regularly.

What is Opticrom?

Opticrom has active ingredients of cromolyn sodium. eHealthMe is studying from 95 Opticrom users. Check the latest studies of Opticrom.

What is Anaphylaxis?

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death) is found to be associated with 1,936 drugs and 2,858 conditions by eHealthMe. Check the latest studies of Anaphylaxis.



On Aug, 05, 2026

93 people reported to have side effects when taking Opticrom.
Among them, 11 people (11.83%) have Anaphylaxis.

Could Opticrom cause Anaphylaxis?

Among these 11 people:

What is the gender of people who have Anaphylaxis when taking Opticrom? *

  • female: 90.91 %
  • male: 9.09 %

What is the age of people who have Anaphylaxis when taking Opticrom? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 9.09 %
  • 20-29: 0.0 %
  • 30-39: 90.91 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Opticrom? *

  1. Advair Hfa: 11 people, 100.00%
  2. Xolair: 11 people, 100.00%
  3. Ventolin: 10 people, 90.91%
  4. Theophylline: 10 people, 90.91%
  5. Apixaban: 10 people, 90.91%
  6. Combivent Respimat: 10 people, 90.91%
  7. Nucala: 8 people, 72.73%
  8. Albuterol: 5 people, 45.45%
  9. Lamotrigine: 5 people, 45.45%
  10. Prednisone: 5 people, 45.45%

What are other side effects people have besides Anaphylaxis? *

  1. Nausea (feeling of having an urge to vomit): 10 people, 90.91%
  2. Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 10 people, 90.91%
  3. Confusion: 10 people, 90.91%
  4. Dizziness: 10 people, 90.91%
  5. Fatigue (feeling of tiredness): 10 people, 90.91%
  6. Forced Expiratory Volume Decreased (decreased lung expired air volume): 10 people, 90.91%
  7. Heart Rate Increased: 10 people, 90.91%
  8. High Blood Pressure: 10 people, 90.91%
  9. Hypotension (abnormally low blood pressure): 10 people, 90.91%
  10. Injection Site Pain: 10 people, 90.91%

What are the existing conditions these people have? *

  1. Asthma: 11 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Opticrom and have Anaphylaxis?

- Check whether Anaphylaxis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Opticrom:

Anaphylaxis treatments and more:

How severe was Anaphylaxis and when was it recovered:

Expand to all the drugs that have ingredients of cromolyn sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Opticrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anaphylaxis:

Browse all the conditions that are associated with Anaphylaxis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Opticrom) and Opticrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: